
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc experienced substantial growth, with last twelve months (LTM) calculated billings increasing nearly 44% year-over-year to $671 million and client count rising by 25% year-over-year, indicating strong demand for its services. The company also reported a revenue increase of 46% year-over-year to $170.7 million, outpacing consensus estimates and reflecting effective market penetration and customer engagement. Additionally, guidance for future revenue suggests continued positive momentum, forecasting a 25% year-over-year increase in projected annual revenue, further supported by expectations of market share gains and growing utilization rates.
Bears say
Hinge Health Inc. faces a negative outlook due to expectations of a macro-driven weak spending environment impacting growth in FY26. Despite providing guidance for non-GAAP operating income and margins that surpass consensus estimates, the company's reliance on employee utilization to drive billings growth introduces additional risk, warranting a lower EV/revenue multiple compared to peers. Furthermore, competition is intensifying not from direct rivals but from budgetary constraints leading potential clients to delay decisions, which could adversely affect Hinge's future revenue potential.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares